Your browser doesn't support javascript.
loading
Impact of varicella vaccine on nosocomial outbreaks and management of post exposure prophylaxis following in a paediatric hospital.
Gentile, Angela; Giglio, Norberto; Lucion, Maria Florencia; Martínez, Ana Clara; Pejito, Natalia; Juarez, Maria Del Valle.
Affiliation
  • Gentile A; Epidemiology, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina.
  • Giglio N; Epidemiology, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina.
  • Lucion MF; Epidemiology, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina.
  • Martínez AC; Diego Azul Regional Maternity Hospital, Buenos Aires, Argentina.
  • Pejito N; Epidemiology, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina.
  • Juarez MDV; Epidemiology, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina.
PLoS One ; 16(5): e0251496, 2021.
Article in En | MEDLINE | ID: mdl-34014962
ABSTRACT

INTRODUCTION:

In 2015, varicella vaccine was introduced to the National Immunization Programme in a one-dose regimen for infants aged 15 months. The aim of this study was to describe and compare the epidemiologic characteristics, management strategies and costs of varicella outbreaks in Ricardo Gutierrez Children's Hospital (HNRG) from 2000 to 2019, before (PreV period) and after (PostV period) the introduction of the varicella vaccine.

METHODS:

A retrospective, analytic study of the impact of nosocomial varicella outbreaks at the HNRG, based on active epidemiologic surveillance. We compared nosocomial varicella outbreaks rates (per 10,000 discharges) between PreV and PostV, excluding the intervention year (2015).

RESULTS:

During PreV, an average of 15.87 (13.91-18.02) outbreaks per year was observed and in PostV 5.5 per year (3.44-8.32). Outbreaks adjusted by all cause discharges showed a reduction of 59.13% (-36.68%, -73.62%) after vaccine introduction. Considering that in PreV the average of susceptible cases per outbreak was 5.0 and in PostV 7.8, with a cost per susceptible of AR$ $6,522 (80.27 USD) PreV and 6,708 PostV the economic impact on the reduction of outbreaks after the introduction of the vaccine, showed an estimated average savings per year of AR$ -252,128 AR$ (-3,103.11 USD).

CONCLUSIONS:

The number of annual varicella hospital outbreaks at the HNRG decreased significantly after varicella vaccine was introduced to NIP in Argentina with a relevant reduction in terms of costs.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chickenpox / Cross Infection / Chickenpox Vaccine Type of study: Observational_studies / Risk_factors_studies Limits: Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: America do sul / Argentina Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chickenpox / Cross Infection / Chickenpox Vaccine Type of study: Observational_studies / Risk_factors_studies Limits: Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: America do sul / Argentina Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: